Prominent Wall Street short sellers: Investors should focus on defensive stocks earnings and wait for clearer employment data.
Morgan Stanley maintains a neutral stance on defensive stocks related to cyclical sectors in the economy, waiting for 'clearer' employment data. The bank believes employment data is a key driving factor for the year-end stock market.
Best Real Estate Growth Stocks as the Sector Is Seeing a Revival
Here Are the Most Attractive High-yield Dividend Stocks Right Now
Citigroup Upgrades Sabra Health Care REIT to Buy From Neutral, Price Target Is $20
Citi Upgrades Sabra Health Care REIT Inc(SBRA.US) to Buy Rating, Raises Target Price to $20
Citi analyst Nicholas Joseph upgrades $Sabra Health Care REIT Inc(SBRA.US)$ to a buy rating, and adjusts the target price from $15 to $20.According to TipRanks data, the analyst has a success rate
Truist Financial Maintains Sabra Health Care REIT Inc(SBRA.US) With Buy Rating, Maintains Target Price $18
Truist Financial analyst Michael Lewis maintains $Sabra Health Care REIT Inc(SBRA.US)$ with a buy rating, and maintains the target price at $18.According to TipRanks data, the analyst has a success